Ausgabe 6/2018
Inhalt (19 Artikel)
Bispecific Antibodies for the Treatment of Acute Myeloid Leukemia
- Acute Myeloid Leukemias (H Erba, Section Editor)
Daniel G. Guy, Geoffrey L. Uy
Hereditary Myelodysplastic Syndrome and Acute Myeloid Leukemia: Diagnosis, Questions, and Controversies
- Acute Myeloid Leukemias (H Erba, Section Editor)
Imo J. Akpan, Afaf E. G. Osman, Michael W. Drazer, Lucy A. Godley
Chronic Myeloid Leukemia: Beyond BCR-ABL1
- Molecular Testing and Diagnostics (J Khoury, Section Editor)
Ting Zhou, L. Jeffrey Medeiros, Shimin Hu
Recent Updates on Chronic Myelomonocytic Leukemia
- Molecular Testing and Diagnostics (J Khoury, Section Editor)
Sanam Loghavi, Joseph D. Khoury
Minimal/Measurable Residual Disease Detection in Acute Leukemias by Multiparameter Flow Cytometry
- Molecular Testing and Diagnostics (J Khoury, Section Editor)
Franklin Fuda, Weina Chen
Myelodysplastic Syndromes: Laboratory Workup in the Context of New Concepts and Classification Criteria
- Molecular Testing and Diagnostics (J Khoury, Section Editor)
Maria Sanz-De Pedro, Wei Wang, Rashmi Kanagal-Shamanna, Joseph D. Khoury
Blastic Plasmacytoid Dendritic Cell Neoplasm
- Molecular Testing and Diagnostics (J Khoury, Section Editor)
Joseph D. Khoury
Hematopoietic Stem Cell Transplantation in the Era of Engineered Cell Therapy
- CART and Immunotherapy (M Ruella, Section Editor)
Jacob S. Appelbaum, Filippo Milano
Novel Immunotherapies for T Cell Lymphoma and Leukemia
- CART and Immunotherapy (M Ruella, Section Editor)
Paola Ghione, Alison J. Moskowitz, Nadia E. K. De Paola, Steven M. Horwitz, Marco Ruella
Leveraging Hypomethylating Agents for Better MDS Therapy
- Myelodysplastic Syndromes (M Savona, Section Editor)
Terrence J. Bradley, Justin M. Watts, Ronan T. Swords
Breast Implant-Associated Anaplastic Large Cell Lymphoma
- T-Cell and Other Lymphoproliferative Malignancies (J Zain, Section Editor)
P. Rastogi, A. K. Deva, H. Miles Prince
Targeted Therapies in CLL: Monotherapy Versus Combination Approaches
- Chronic Lymphocytic Leukemias (N Jain, Section Editor)
Maliha Khan, Tanya Siddiqi
Anti-CD19 Chimeric Antigen Receptor T Cell Therapies: Harnessing the Power of the Immune System to Fight Diffuse Large B Cell Lymphoma
- B-cell NHL, T-cell NHL, and Hodgkin Lymphoma (J Amengual, Section Editor)
Robert Havard, Deborah M. Stephens
Checkpoint Inhibitors Hodgkin Lymphoma and Non-Hodgkin Lymphoma
- B-cell NHL, T-cell NHL, and Hodgkin Lymphoma (J Amengual, Section Editor)
Bei Hu, Ryan Jacobs, Nilanjan Ghosh
Combining Biology and Chemistry for a New Take on Chemotherapy: Antibody-Drug Conjugates in Hematologic Malignancies
- B-cell NHL, T-cell NHL, and Hodgkin Lymphoma (J Amengual, Section Editor)
Helen Ma, Ahmed Sawas
Online and Social Media Resources for Patients with MDS
- Social Media Impact of Hematologic Malignancies (N Pemmaraju, Section Editor)
Nour Abuhadra, Aziz Nazha
Social Media and Hematopoietic Cell Transplantation: a Review of Online Resources and Communities
- Social Media Impact of Hematologic Malignancies (N Pemmaraju, Section Editor)
Sagar S. Patel, Navneet S. Majhail
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCN—Increasing Exposure over Two Years Since Inception of a Disease-Specific Twitter Community
- Social Media Impact of Hematologic Malignancies (N Pemmaraju, Section Editor)
Naveen Pemmaraju, Audun Utengen, Vikas Gupta, Michael A. Thompson, Andrew A. Lane
Leukemic Transformation of Myeloproliferative Neoplasms: Therapeutic and Genomic Considerations
- Myeloproliferative Neoplasms (B Stein, Section Editor)
Bing Li, John O. Mascarenhas, Raajit K. Rampal
